Bilenker Joshua H.

President & CEO at Loxo Oncology, Inc.

Sold, on record
$43.2M
Dollars the filings state
Form 4 sales
17
Latest Dec 11, 2018
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Loxo Oncology, Inc.Plan not stated
    May 15, 2018 2018

    Sold 15,000 shares at $136.51 ($2M)

    Bilenker Joshua H., President & CEO

    Sold 7.6% of holdings ($27M position)182,707 shares left1x usual sizeFiling

  2. 2 Form 4 sale Loxo Oncology, Inc.Unusual
    Jun 20, 2018 +36 days

    Sold 57,000 shares at $178.62 ($10.2M)

    Bilenker Joshua H., President & CEO

    Sold 26.8% of holdings ($38M position)155,707 shares left3.8x usual sizeFiling

  3. 3 Form 4 sale Loxo Oncology, Inc.Plan not stated
    Jul 10, 2018 +20 days

    Sold 15,000 shares at $183.48 ($2.8M)

    Bilenker Joshua H., President & CEO

    Sold 10% of holdings ($27.6M position)135,407 shares left1x usual sizeFiling

  4. 4 Form 4 sale Loxo Oncology, Inc.Plan not stated
    Aug 14, 2018 +35 days

    Sold 20,000 shares at $159.41 ($3.2M)

    Bilenker Joshua H., President & CEO

    Sold 12.9% of holdings ($24.8M position)135,407 shares left1.3x usual sizeFiling

  5. 5 Form 4 sale Loxo Oncology, Inc.Plan not stated
    Sep 13, 2018 +30 days

    Sold 20,000 shares at $166.20 ($3.3M)

    Bilenker Joshua H., President & CEO

    Sold 12.9% of holdings ($25.8M position)135,407 shares left1.3x usual sizeFiling

  6. 6 Form 4 sale Loxo Oncology, Inc.Plan not stated
    Oct 4, 2018 +21 days

    Sold 20,000 shares at $164.94 ($3.3M)

    Bilenker Joshua H., President & CEO

    Sold 12.9% of holdings ($25.6M position)135,407 shares leftFirst sale on recordFiling

  7. 7 Form 4 sale Loxo Oncology, Inc.Plan not stated
    Nov 27, 2018 +54 days

    Sold 20,000 shares at $147.26 ($2.9M)

    Bilenker Joshua H., President & CEO

    Sold 10.8% of holdings ($27.2M position)164,407 shares left1.3x usual sizeFiling

  8. 8 Form 4 sale Loxo Oncology, Inc.Plan not stated
    Dec 11, 2018 +14 days

    Sold 20,000 shares at $135.47 ($2.7M)

    Bilenker Joshua H., President & CEO

    Sold 10.8% of holdings ($25M position)164,407 shares left1.3x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (17)

Form 144 notices and Form 4 sales by Bilenker Joshua H.
Source
Dec 11, 2018Dec 12, 2018Loxo Oncology, Inc.President & CEOForm 4 sale20,000$2.7M10.8%Plan not statedSEC
Nov 27, 2018Nov 28, 2018Loxo Oncology, Inc.President & CEOForm 4 sale20,000$2.9M10.8%Plan not statedSEC
Oct 4, 2018Oct 5, 2018Loxo Oncology, Inc.President & CEOForm 4 sale20,000$3.3M12.9%Plan not statedSEC
Sep 13, 2018Sep 14, 2018Loxo Oncology, Inc.President & CEOForm 4 sale20,000$3.3M12.9%Plan not statedSEC
Aug 14, 2018Aug 15, 2018Loxo Oncology, Inc.President & CEOForm 4 sale20,000$3.2M12.9%Plan not statedSEC
Jul 10, 2018Jul 11, 2018Loxo Oncology, Inc.President & CEOForm 4 sale15,000$2.8M10.0%Plan not statedSEC
Jun 20, 2018Jun 21, 2018Loxo Oncology, Inc.President & CEOForm 4 sale57,000$10.2M26.8%UnusualSEC
May 15, 2018May 16, 2018Loxo Oncology, Inc.President & CEOForm 4 sale15,000$2M7.6%Plan not statedSEC
Apr 25, 2018Apr 26, 2018Loxo Oncology, Inc.President & CEOForm 4 sale15,000$2M7.6%Plan not statedSEC
Mar 14, 2018Mar 15, 2018Loxo Oncology, Inc.President & CEOForm 4 sale15,000$2M7.6%Plan not statedSEC
Feb 13, 2018Feb 14, 2018Loxo Oncology, Inc.President & CEOForm 4 sale15,000$1.4M7.6%Plan not statedSEC
Jan 17, 2018Jan 18, 2018Loxo Oncology, Inc.President & CEOForm 4 sale15,000$1.3M7.6%Plan not statedSEC
Dec 15, 2017Dec 18, 2017Loxo Oncology, Inc.President & CEOForm 4 sale15,000$1.2M7.6%Plan not statedSEC
Nov 28, 2017Nov 29, 2017Loxo Oncology, Inc.President & CEOForm 4 sale15,000$1.1M7.6%Plan not statedSEC
Oct 31, 2017Nov 1, 2017Loxo Oncology, Inc.President & CEOForm 4 sale15,000$1.3M7.4%Plan not statedSEC
Sep 19, 2017Sep 20, 2017Loxo Oncology, Inc.President & CEOForm 4 sale15,000$1.3M7.4%Plan not statedSEC
Aug 15, 2017Aug 16, 2017Loxo Oncology, Inc.President & CEOForm 4 sale15,000$1.1M7.4%Plan not statedSEC